MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $33,756,075 | +346.6% | 116,300 | 0.0% | 0.01% | +300.0% |
| Q3 2022 | $7,558,337 | -3.6% | 116,300 | +6.2% | 0.00% | 0.0% |
| Q2 2022 | $7,838,439 | -27.0% | 109,506 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $10,744,729 | +15.8% | 109,506 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $9,280,000 | +15.2% | 109,506 | +8.4% | 0.00% | 0.0% |
| Q3 2021 | $8,059,000 | +12.3% | 101,006 | +37.1% | 0.00% | 0.0% |
| Q2 2021 | $7,175,000 | -42.4% | 73,659 | -30.9% | 0.00% | -33.3% |
| Q1 2021 | $12,465,000 | -25.0% | 106,566 | -28.7% | 0.00% | -25.0% |
| Q4 2020 | $16,619,000 | -12.2% | 149,488 | -6.3% | 0.00% | -20.0% |
| Q3 2020 | $18,935,000 | +17.9% | 159,482 | +12.5% | 0.01% | 0.0% |
| Q2 2020 | $16,057,000 | +81.3% | 141,788 | +6.9% | 0.01% | +66.7% |
| Q1 2020 | $8,856,000 | -24.4% | 132,652 | +3.2% | 0.00% | 0.0% |
| Q4 2019 | $11,712,000 | +56.3% | 128,545 | +47.9% | 0.00% | +50.0% |
| Q3 2019 | $7,493,000 | -13.2% | 86,899 | +5.5% | 0.00% | -33.3% |
| Q2 2019 | $8,632,000 | -16.3% | 82,350 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $10,315,000 | +11.1% | 82,350 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $9,282,000 | -28.9% | 82,350 | +35.1% | 0.00% | -25.0% |
| Q3 2018 | $13,052,000 | – | 60,954 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |